STANDARD BIOTLS (LAB)
(Delayed Data from NSDQ)
$1.80 USD
+0.25 (16.13%)
Updated Aug 15, 2024 03:59 PM ET
After-Market: $1.80 0.00 (0.00%) 4:54 PM ET
4-Sell of 5 4
F Value F Growth C Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/5/24 |
---|---|
Current Quarter | -0.08 |
EPS Last Quarter | -0.08 |
Last EPS Surprise | -33.33% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.30 |
Next Year | -0.18 |
EPS (TTM) | -0.54 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 42.45M | 46.10M | 172.25M | 200.05M |
# of Estimates | 2 | 1 | 2 | 2 |
High Estimate | 42.50M | 46.10M | 172.50M | 210.10M |
Low Estimate | 42.40M | 46.10M | 172.00M | 190.00M |
Year ago Sales | 25.37M | 28.19M | 106.34M | 172.25M |
Year over Year Growth Est. | 67.32% | 63.53% | 61.98% | 16.14% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.08 | -0.07 | -0.30 | -0.18 |
# of Estimates | 1 | 1 | 1 | 1 |
Most Recent Consensus | NA | NA | NA | NA |
High Estimate | -0.08 | -0.07 | -0.30 | -0.18 |
Low Estimate | -0.08 | -0.07 | -0.30 | -0.18 |
Year ago EPS | -0.15 | -0.08 | -0.41 | -0.30 |
Year over Year Growth Est. | 46.67% | 12.50% | 26.83% | 40.00% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 1 | 1 | 1 | 1 |
Down Last 60 Days | 1 | 1 | 1 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.08 | -0.07 | -0.30 | -0.18 |
7 Days Ago | -0.08 | -0.07 | -0.30 | -0.18 |
30 Days Ago | -0.06 | -0.06 | -0.23 | -0.12 |
60 Days Ago | -0.06 | -0.06 | -0.23 | -0.12 |
90 Days Ago | -0.06 | -0.06 | -0.23 | -0.12 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.08 | -0.07 | -0.30 | -0.18 |
Zacks Consensus Estimate | -0.08 | -0.07 | -0.30 | -0.18 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.08 | -0.23 | -0.08 | -0.15 | NA |
Estimate | -0.06 | -0.09 | -0.13 | NA | NA |
Difference | -0.02 | -0.14 | 0.05 | NA | -0.04 |
Surprise | -33.33% | -155.56% | 38.46% | NA | -50.14% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more